The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 24, 2018

Filed:

Oct. 12, 2015
Applicant:

Corsens Medical Ltd., Tel Aviv, IL;

Inventor:

Alon Marmor, Kfar Hanania, IL;

Assignee:

CORSENS MEDICAL LTD., Tel Aviv, IL;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61B 5/11 (2006.01); A61B 5/02 (2006.01); A61B 5/0452 (2006.01); A61B 5/00 (2006.01); A61B 8/08 (2006.01);
U.S. Cl.
CPC ...
A61B 5/1102 (2013.01); A61B 5/02028 (2013.01); A61B 5/0452 (2013.01); A61B 5/7278 (2013.01); A61B 5/7282 (2013.01); A61B 5/4824 (2013.01); A61B 5/6831 (2013.01); A61B 5/746 (2013.01); A61B 8/485 (2013.01); A61B 2505/01 (2013.01); A61B 2562/0204 (2013.01); A61B 2562/0219 (2013.01);
Abstract

Quantitatively diagnosing ischemia by non-invasively sensing mechanical vibrations from mechanical contraction of a ventricle to measure a time duration of an isovolumetric contraction and a peak endocardial acceleration (PEA) of the heart during the IVCT and calculating a myocardial contractility index (MCI) of the subject, for example MCI=PEA/IVCT. Comparing the MCI of the subject during the sensing period to a baseline MCI which is defined as the baseline MCI of the subject or a representative value of the baseline MCI of a population of subjects less a predetermined value, and then determining by a processor whether the MCI of the subject declined during the sensing period by at least a predetermined amount relative to the baseline MCI. Also allows determination of an amount of viable myocardium, existence of total occlusion of a coronary artery, myocardial infarction and whether thrombolysis has been effective so as to be discontinued.


Find Patent Forward Citations

Loading…